News
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.
The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on allegations that vaccine testing results were delayed until after the 2020 ...
Fox Business on MSN6h
Pfizer faces accusations over timing of COVID vaccine resultsRep. Russell Fry, R-S.C., discusses the House probe into Pfizer’s release of COVID vaccine results and more on ‘Varney & Co.’ Country icon George Strait brings fans to tears during emotional moment at ...
Stillman College research scholars and professors hosted a health seminar and discussion on why health matters at Brown ...
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
Novo Nordisk's CEO, who led its boom driven by obesity and diabetes medications only to see that success stall, is stepping ...
10h
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
The EU’s General Court ruled that European Commission President Ursula von der Leyen violated transparency laws by ...
How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our ...
However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results